Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US i
China's Belt and Road Initiative (BRI) has left scores of Lower and Middle-Income Countries (LMIC) saddled with "hidden debts." China is using debt rather than aid to establish a dominant position in the international development finance market.
Bangalore (Karnataka)/ Delhi/ Ahmedabad (Gujarat) [India], January 25 (ANI/GPRC): CIGNEX, and Excellerent today announced their merger with Relevance Lab, to become a global powerhouse in offering digital transformation and cloud services. With this merger, Relevance Lab, headquartered in Si
Dhahran [Saudi Arabia], January 25 (ANI/PRNewswire): The King Abdulaziz Center for World Culture (Ithra) champions knowledge exploration and scientific discovery at the inaugural edition of the Diriyah Biennale Foundation's Islamic Arts Biennale. The Center takes a multidisciplinary approach
New Delhi [India], January 24 (ANI/PNN): Gaudium IVF, one of the leading-approved fertility treatment centers well known for utilizing the most advanced reproductive technology, has bet big on India's future to emerge as a popular hotspot for IVF treatments. The fertility clinic has reported
An anti-ageing gene discovered in a centenarian population has been proven to reduce the biological age of the heart by ten years. The discovery, which was spearheaded by academics at the University of Bristol and the MultiMedica Group in Italy and was published in Cardiovascular Research, p
Dadri (Uttar Pradesh) [India], January 23 (ANI/BusinessWire India): After the consecutive success of previous editions of its annual flagship incubation program, the Atal Incubation Centre (AIC) - Shiv Nadar Institution of Eminence is back with Venture Challenge 6.0, a closed-door elevator p
A mechanism has been identified by researchers from the University of Michigan Rogel Cancer Center that explains why some patients' cancers grow in response to immunotherapy rather than shrinking.
According to a study led by the Mayo Clinic Comprehensive Cancer Center, women who have cancer in one breast may be more likely to develop cancer in the opposite breast if they carry specific genetic changes that predispose them to develop breast cancer.
Wu Zunyou, the chief epidemiologist of China's Center for Disease Control and Prevention has claimed that the present "wave of epidemic has already infected about 80 pc of the people" in China.